表紙画像

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors

Recently, combining histone deacetylase (HDAC) inhibitors with chemotherapeutic drugs or agents, in particular epidermal growth factor receptor (EGFR) inhibitors, is considered to be one of the most encouraging strategy to enhance the efficacy of the antineoplastic agents and decrease or avoid drug...

保存先:

書誌詳細
主要な著者:	Tarek S. Ibrahim (著者), Azizah M. Malebari (著者), Mamdouh F. A. Mohamed (著者)
フォーマット:	図書
出版事項:	MDPI AG, 2021-11-01T00:00:00Z.
主題:	article
オンライン･アクセス:	Connect to this object online.
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents
著者:: Chao Wang, 等
出版事項: (2024)

Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents
著者:: Ahmed M. Shawky, 等
出版事項: (2021)

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
著者:: Mourad AAE, 等
出版事項: (2020)

Naproxen Based 1,3,4-Oxadiazole Derivatives as EGFR Inhibitors: Design, Synthesis, Anticancer, and Computational Studies
著者:: Mohammad Mahboob Alam, 等
出版事項: (2021)

Acute toxicity of 5-(2-, 3-, 4-methoxyphenyl, (3,4,5-trimethoxyphenyl)-)-1,2,4-triazole-3-thiones and its thioderivatives
著者:: Yu. G. Samelyuk, 等
出版事項: (2015)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs
著者:: Lukas von Bredow, 等
出版事項: (2022)

Synthesis and Antiproliferative Activity of Novel Heterocyclic Indole-Trimethoxyphenyl Conjugates
著者:: Michael M. Cahill, 等
出版事項: (2017)

Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile
著者:: Aml E.-S. Mghwary, 等
出版事項: (2019)

2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
著者:: Mostafa M. Elbadawi, 等
出版事項: (2022)

Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity
著者:: Zhengshui Xu, 等
出版事項: (2024)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
著者:: Qingwei Zhang, 等
出版事項: (2020)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
著者:: Qingwei Zhang, 等
出版事項: (2020)

Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity
著者:: Mai A. E. Mourad, 等
出版事項: (2023)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
著者:: Tim Fischer, 等
出版事項: (2018)

Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
著者:: Mohamed A. Mahmoud, 等
出版事項: (2024)

Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells
著者:: Yoojin Song, 等
出版事項: (2020)

Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors
著者:: Dong-Jun Fu, 等
出版事項: (2020)

Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
著者:: Fabiana Sélos Guerra, 等
出版事項: (2021)

Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF<sup>V600E</sup>: Design, Synthesis, and Antiproliferative Activity
著者:: Lamya H. Al-Wahaibi, 等
出版事項: (2023)

Design, synthesis and antitumor activity of 3,4,5-Trisubstituted Isoxazoles
著者:: Kanghui Duan, 等
出版事項: (2024)

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer
著者:: Dafeng Guo, 等
出版事項: (2022)

Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors
著者:: Md. Jahangir Alam, 等
出版事項: (2022)

Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations
著者:: Antonio Curcio, 等
出版事項: (2024)

Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR
著者:: Reham R. Khattab, 等
出版事項: (2021)

Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
著者:: Lamya H. Al-Wahaibi, 等
出版事項: (2022)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
著者:: Al-Sanea MM, 等
出版事項: (2020)

EGFR is a potential dual molecular target for cancer and Alzheimer's disease
著者:: Hee-Jeong Choi, 等
出版事項: (2023)

An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor
著者:: Mengfei Wang, 等

Design, Synthesis, and Evaluation of Benzoheterocyclic-Containing Derivatives as Novel HDAC1 Inhibitors
著者:: Min-Ru Jiao, 等
出版事項: (2022)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
著者:: Magda A.-, 等
出版事項: (2018)

Correction to: Fischer et al., Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
出版事項: (2018)

Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAF<sup>V600E</sup> Dual Inhibitors Endowed with Antiproliferative Activity
著者:: Lamya H. Al-Wahaibi, 等
出版事項: (2023)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
著者:: Elizabeth A. Thomas
出版事項: (2014)

Design, Synthesis and molecular docking study of hybrids of quinazolin-4(3H)-one as anticancer agents
著者:: Sukanya Nara, 等

Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1
著者:: Patrycja Wińska, 等
出版事項: (2023)

New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
著者:: Mohammad M. Al-Sanea, 等
出版事項: (2023)

Synthesis and Antiproliferative Effect of 3,4,5-Trimethoxylated Chalcones on Colorectal and Prostatic Cancer Cells
著者:: Cécile Letulle, 等
出版事項: (2024)

Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer
著者:: Megha Jethwa, 等
出版事項: (2024)

Synthesis and biological activity evaluation of new isatin-gallate hybrids as antioxidant and anticancer agents (in vitro) and in silico study as anticancer agents and coronavirus inhibitors
著者:: May Mohammed Jawad Al-Mudhafar, 等
出版事項: (2024)

Novel Coumarin-Nucleobase Hybrids with Potential Anticancer Activity: Synthesis, In Vitro Cell-Based Evaluation, and Molecular Docking
著者:: Maiara Correa de Moraes, 等
出版事項: (2024)